Principia Biopharma, Inc.
(NASDAQ : PRNB)

( )
PRNB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.55%44.190.9%$1265.49m
ABBVAbbVie, Inc. 0.85%107.311.9%$1024.22m
JNJJohnson & Johnson 0.54%164.820.7%$998.60m
MRKMerck & Co., Inc. 1.40%73.050.7%$880.20m
LLYEli Lilly & Co. 1.65%232.061.1%$598.53m
BMYBristol-Myers Squibb Co. 0.78%60.621.0%$573.53m
AZNAstraZeneca Plc 1.26%59.481.0%$335.33m
NVSNovartis AG 0.93%83.570.2%$162.07m
CRVSCorvus Pharmaceuticals, Inc. -6.14%7.030.7%$143.77m
GSKGlaxoSmithKline Plc 0.15%39.340.2%$135.46m
SNYSanofi 0.50%48.720.2%$123.92m
RGENRepligen Corp. 3.55%324.216.8%$120.88m
RPRXRoyalty Pharma Plc 2.32%37.130.1%$120.28m
VTRSViatris, Inc. 0.68%13.340.0%$108.50m
NVONovo Nordisk A/S 1.24%102.120.1%$102.45m

Company Profile

Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.